Cytochrome P450 4F subfamily: At the crossroads of eicosanoid and drug metabolism
Henry W. Strobel, Auinash Kalsotra
págs. 589-611
Treating insomnia: Current and investigational pharmacological approaches
Keith A. Wafford, Bjarke Ebert, Stephen Deacon
págs. 612-629
Nobuhiro Nishiyama, Kazunori Kataoka
págs. 630-648
Intestinal tract injury by drugs: Importance of metabolite delivery by yellow bile road
Mary F. Kanz, Mary Treinen-Moslen
págs. 649-667
Shinji Takai, Denan Jin, Michiko Muramatsu, Mizuo Miyazaki
págs. 668-676
Charles D. Nichols
págs. 677-700
Therapeutic options for 5-lipoxygenase inhibitors
Oliver Werz, Dieter Steinhilber
págs. 701-718
Brice Marcet, Jean-Marie Boeynaems
págs. 719-732
Aspirin resistance: Truth or dare
Marie Lordkipanidzé, Jean G. Diodati, Donald A. Palisaitis, Chantal Pharand
págs. 733-743
Vladimir Chubanov, Benjamin R. Rost, Alexander Dietrich, Hermann Kalwa, Thomas Gudermann
págs. 744-760
Cytochrome P450s and cholesterol homeostasis
Irina A. Pikuleva
págs. 761-773
Targeting BAFF: Immunomodulation for autoimmune diseases and lymphomas
Charles R. Mackay, Andrew P.R. Sutherland, Fabienne Mackay
págs. 774-786
Mechanisms of type I food allergy
Erika Jensen-Jarolim, Eva Untersmayr
págs. 787-798
Lipid phosphatases as a possible therapeutic target in cases of type 2 diabetes and obesity
Hiroshi Tsuneki, Toshiyasu Sasaoka, Tsutomu Wada
págs. 799-809
Synaptic plasticity and phosphorylation
Hey-Kyoung Lee
págs. 810-832
© 2001-2024 Fundación Dialnet · Todos los derechos reservados